SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-010509
Filing Date
2022-07-01
Accepted
2022-07-01 16:00:54
Documents
13
Period of Report
2022-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aytu-20220629x8k.htm   iXBRL 8-K 35420
2 EX-10.1 aytu-20220629xex10d1.htm EX-10.1 105412
  Complete submission text file 0001558370-22-010509.txt   283878

Data Files

Seq Description Document Type Size
3 EX-101.SCH aytu-20220629.xsd EX-101.SCH 3052
4 EX-101.LAB aytu-20220629_lab.xml EX-101.LAB 16027
5 EX-101.PRE aytu-20220629_pre.xml EX-101.PRE 10158
7 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20220629x8k_htm.xml XML 4868
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 221061311
SIC: 2834 Pharmaceutical Preparations